Thymosin Alpha-1 10 mg

Peptide Sciences USA
  • Active Substance: Thymosin Alpha-1
  • Concentration: 10 mg per vial
  • Pack Size: Single vial (lyophilized powder)
  • Manufacturer: Peptide Sciences USA
  • Brand Name: Thymosin
  • Molecular Formula: C129H215N33O55
  • Molecular Weight: 3108.3 g/mol
  • Synonyms: TA1, Zadaxin, Immune Modulator Peptide
Manufacturer Peptide Sciences USA
Brand Thymosin
Substance Thymosin Alpha-1
Concentration 10 mg
Pack Size vial
Out of Stock

Thymosin Alpha-1 (TA1) is a naturally occurring peptide fragment derived from the prothymosin alpha protein, known for its role in modulating immune function. Supplied as a 10 mg injectable vial by Peptide Sciences USA, this research-grade compound is under investigation for its immunoregulatory effects in viral models, autoimmune responses, and general immune system optimization.

Mechanism of Action

Thymosin Alpha-1 binds to Toll-like receptors on immune cells, particularly T lymphocytes and dendritic cells, initiating a cascade that enhances cytokine production and improves T-cell activation. This leads to a more responsive and balanced immune system, especially in immunocompromised or stressed biological models.

TA1 has been shown to increase the activity of CD4+/CD8+ cells, promote natural killer (NK) cell cytotoxicity, and reduce pro-inflammatory cytokines such as TNF-alpha and IL-6. It may also upregulate MHC class I expression, which plays a key role in the recognition of infected or malignant cells. These properties make it a valuable subject of study for chronic viral infections, inflammatory disorders, and immune system recovery.

Key Features & Benefits

  • Immune System Enhancement: Supports T-cell and NK-cell function in models of immune suppression or viral infection.
  • Anti-Inflammatory Properties: Reduces overactive cytokine responses and inflammation-related damage.
  • Research-Backed Peptide: Studied globally in over 30 clinical trials for its safety and efficacy under lab conditions.
  • Supports Cellular Defense: May improve host response against intracellular pathogens in immune-related research.
  • Made in the USA: Produced by Peptide Sciences to high standards of purity and sterility.

Frequently Asked Questions

1. What is Thymosin Alpha-1?
Thymosin Alpha-1 (TA1) is a peptide derived from the thymus, studied for its ability to enhance immune responses and modulate inflammation in laboratory settings.
2. How long does Thymosin Alpha-1 take to work?
In research models, biological effects may be observed within several days of consistent administration, depending on dosage and subject health parameters.
3. What is Thymosin Alpha-1 used for?
TA1 is primarily studied for immune system stimulation, viral infection models, immune recovery post-injury, and anti-inflammatory research.
4. Is Thymosin Alpha-1 safe?
Thymosin Alpha-1 has a favorable safety profile in research and clinical settings, with minimal reported adverse effects when used as directed in preclinical studies.
5. Is Thymosin Alpha-1 FDA approved?
It is FDA-approved for specific medical indications outside the United States (e.g., hepatitis B/C), but in the U.S., it is limited to investigational or research use only.